Abstract
The progress in AIDS research has been hampered by the lack of a small and practical animal model susceptible to HIV infection, suitable for a rapid testing of antiviral compounds and vaccines. Over the past 20 years, different attempts have been made to develop various models for AIDS in mice. An ensemble of studies carried out in several laboratories during the past decade by using SCID mice transplanted with human cells and infected with HIV have revealed that these chimeric human-mouse models can indeed represent valuable animal systems for addressing a variety of important issues in AIDS research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albert, S. E., McKerlie, C., Pester, A., Edgell, B. J., Carlyle, J., Petric, M., and Chamberlain, J. W., 1997, Time-dependent induction of protective anti-influenza immune responses in human peripheral blood lymphocyte/SCID mice. Immunology. 159:1393.
Andrus, L., Prince, A. M., Bernal, I., McCormack, P., Lee, D. H., Gorny, M. K., and Zolla-Pazner, S., 1998, Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant. J Infect Dis. 177:889.
Bentwich, Z., Kalinkovich, A., and Weisman, Z., 1995, Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 16:187.
Berkowitz, R. D., Alexander, S., and McCune, J. M., 2000, Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus. AIDS Res Hum Retroviruses. 16:1039.
Berkowitz, R. D., Beckerman, K. P., Schall, T. J., and McCune, J. M., 1998, CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T-cell differentiation. J Immunol. 161:3702.
Berkowitz, R. D., van’t Wout, A. B., Kootstra, N. A., Moreno, M. E., Linquist-Stepps, V. D., Bare, C., Stoddart, C. A., Schuitemaker, H., and McCune, J. M., 1999, R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4 type pathogenicity in human thymus. J Virol. 73:7817.
Bombil, F., Latinne, D., Kints, J. P., and Bazin, H., 1996, Human recombinant interleukin-4 (HurIL-4) improves SCID mouse reconstitution with human peripheral blood lymphocytes. Immunobiology. 196:437.
Bosma, M. J., and Carroll, A. M., 1991, The SCID mouse mutant: definition, characterization, and potential uses. Ann Rev Immunol. 9:323.
Boyle, M. J., Connors, M., Flanigan, M. E., Geiger, S. P., Ford, H. Jr., Baseler, M., Adelsberger, J., Davey, R. T. Jr., and Lane, H. C., 1995, The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy. J Immunol. 154:6612.
Clerici, M., Sarin, A., Coffman, R. L., Wynn, T. A., Blatt, S. P., Hendrix, C. W., Wolf, S. F., Shearer, G. M., and Henkart, P. A., 1994, Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA. 91:11811.
de Quiros, J. C., Shupert, W. L., McNeil, A. C., Gea-Banacloche, J. C., Flanigan, M., Savage, A., Martino, L., Weiskopf, E. E., Imamichi, H., Zhang, Y. M., Adelsburger, J., Stevens, R., Murphy, P. M., Zimmerman, P. A., Hallahan, C. W., Davey, R. T. Jr., and Connors, M., 2000, Resistance to Replication of Human Immunodeficiency Virus Challenge in SCIDHu Mice Engrafted with Peripheral Blood Mononuclear Cells of Nonprogressors Is Mediated by CD8+ T-Cells and Associated with a Proliferative Response to p24 Antigen. J Virol. 74:2023.
Delhem, N., Hadida, F., Gorochov, G., Carpentier, F., de Cavel, J. P., Andreani, J. F., Autran, B., and Cesbron, J. Y., 1998, Primary Th1 cell immunization against HIVgp160 in SCIDhu mice coengrafted with peripheral blood lymphocytes and skin. J Immunol. 161:2060.
Di Fabio, S., Giannini, G., Lapenta, C., Spada, M., Binelli, A., Germinario, E., Sestili, P., Belardelli, F., Proietti, E., and Vella, S., 2001, Vaginal transmission of HIV-1 in hu-SCID mice:a new model for the evaluation of vaginal microbicides. AIDS. 15:2231.
Duchosal, M. A., McConahey, P. J., Robinson, C. A., and Dixon, F. J., 1990, Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med. 172:985.
Fais, S., Lapenta, C., Santini, S. M., Spada, M., Parlato, S., Logozzi, M., Rizza, P., and Belardelli, F., 1999, Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. J Virol. 73:6453.
Folks, T., Rowe, T., Villinger, F., Parekh, B., Mayne, A., Anderson, D., McClure, H., and Ansari, A. A., 1997, Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques. J Med Primatol. 26:181.
Garaci, E., Aquaro, S., Lapenta, C., Amendola, A., Spada, M., Covaceuszach, S., Perno, C. F., and Belardelli, F., 2003, Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice. Proc Natl Acad Sci USA. 100:8927.
Gauduin, M. C., Allaway, G. P., Olson, W. C., Weir, R., Maddon, P. J., and Koup, R. A., 1998, CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates. J Virol. 72:3475.
Gauduin, M. C., Parren, P. W., Weir, R., Barbas, C. F., Burton, D. R., and Koup, R. A., 1997, Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat Med. 3:1389.
Gauduin, M. C., Safrit, J. T., Weir, R., Fung, M. S., and Koup, R. A., 1995, Pre-and post-exposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody. J Infect Dis. 171:1203.
Gulizia, R. J., Levy, J. A., and Mosier, D. E., 1996, The envelope gp120 gene of human immunodeficiency virus type 1 determines therate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes. J Virol. 70:4184.
Karlsson, G. B., Halloran, M., Schenten, D., Lee, J., Racz, P., Tenner-Racz, K., Manola, J., Gelman, R., Etemad-Moghadam, B., Desjardins, E., Wyatt, R., Gerard, N. P., Marcon, L., Margolin, D., Fanton, J., Axthelm, M. K., Letvin, N. L., and Sodroski, J., 1998, The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med. 188:1159.
Khanna, K. V., Whaley, K. J., Zeitlin, L., Moench, T. R., Mehrazar, K., Cone, R. A., Liao, Z., Hildreth, J. E., Hoen, T. E., Shultz, L., and Markham, R. B., 2002, Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest. Jan 109:205.
Kish, T. M., Budgeon, L. R., Welsh, P. A., and Howett, M. K., 2001, Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection. Am J Pathol. 159:2331.
Lapenta, C., Fais, S., Rizza, P., Spada, M., Logozzi, M. A., Parlato, S., Santini, S. M., Pirillo, M., Belardelli, F., and Proietti, E., 1997, U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies. Antiviral Res. 36:81.
Lapenta, C., Parlato, S., Spada, M., Santini, S. M., Rizza, P., Logozzi, M., Proietti, E., Belardelli, F., and Fais, S., 1998, Human lymphoblastoid CD4(+) T-cells become permissive to macrophage-tropicstrains of human immunodeficiency virus type 1 after passage into severe combined immunodeficient mice through in vivo upregulation of CCR5: in vivo dynamics of CD4(+) T-cell differentiation in pathogenesis of AIDS. J Virol. 72:10323.
Lapenta, C., Santini, S. M., Logozzi, M., Spada, M., Andreotti, M., Di Pucchio, T., Parlato, S., and Belardelli, F., 2003, Potent Immune Response against HIV-1 and Protection from Virus Challenge in hu-PBL-SCID Mice Immunized with Inactivated Virus-pulsed Dendritic Cells Generated in the Presence of IFN-a. J Exp Med. 198:361.
Lapenta, C., Santini, S. M., Proietti, E., Rizza, P., Logozzi, M., Spada, M., Parlato, S., Fais, S., Pitha, P. M., and Belardelli, F., 1999, Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T-cells from virus-induced depletion in SCID mice transplanted with human cells. Virology. 263:78.
Markham, R. B., Schwartz, D. H., Templeton, A., Margolick, J. B., Farzadegan, H., Vlahov, D., and Yu, X. F., 1996, Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells. J Virol. 70:6947.
McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M., and Weissman, I. L., 1988, The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 241:1632.
McCune, J. M., Namikawa, R., Shih, C. C., Rabin, L., and Kaneshima, H., 1990, Suppression of HIV infection in AZT-treated SCID-hu mice. Science. 247:564.
McKinney, D. M., Lewinsohn, D. A., Riddell, S. R., Greenberg, P. D., and Mosier, D. E., 1999, The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. J Immunol. 163:861.
Mima, T., Saeki, Y., Ohshima, S., Nishimoto, N., Matsushita, M., Shimizu, M., Kobayashi, Y., Nomura, T., and Kishimoto, T., 1995, Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T-cell populations oligoclonally expanding in the rheumatoid joints. J Clin Invest. 96:1746.
Miura, Y., Misawa, N., Kawano, Y., Okada, H., Inagaki, Y., Yamamoto, N., Ito, M., Yagita, H., Okumura, K., Mizusawa, H., and Koyanagi, Y., 2003, Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci USA. 100:2777.
Miura, Y., Misawa, N., Maeda, N., Inagaki, Y., Tanaka, Y., Ito, M., Kayagaki, N., Yamamoto, N., Yagita, H., Mizusawa, H., and Koyanagi, Y., 2001, Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T-cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med. 193:651.
Mosier, D. E., 1996, Humanizing the mouse. Semin Immunol. 8:185.
Mosier, D. E., Gulizia, R. J., Baird, S. M., and Wilson, D. B., 1988, Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 335:256.
Mosier, D. E., Gulizia, R. J., Baird, S. M., Wilson, D. B., Spector, D. H., and Spector, S. A., 1991, Human immunodeficiency virus infection of human-PBL-SCID mice. Science. 251:791.
Mosier, D. E., Gulizia, R. J., MacIsaac, P. D., Corey, L., and Greenberg, P. D., 1993, Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci USA. 90:2443.
Mosier, D. E., Gulizia, R. J., MacIsaac, P. D., Torbett, B. E., and Levy, J. A., 1993, Rapid loss of CD4+ T-cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science. 260: 689.
Nakao, R., Hanada, N., Asano, T., Hara, T., Abdus Salam, M., Matin, K., Shimazu, Y., Nakasone, T., Horibata, S., Aoba, T., Honda, M., Amagasa, T., and Senpuku, H., 2003, Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte. Immunology. 109:271.
Picchio, G. R., Valdez, H., Sabbe, R., Landay, A. L., Kuritzkes, D. R., Lederman, M. M., and Mosier, D. E., 2000, Altered viral fitness of HIV-1 following failure of protease inhibitorbased therapy. J Acquir Immune Defic Syndr. 25:289.
Poignard, P., Sabbe, R., Picchio, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W., Mosier, D. E., and Burton, D. R., 1999, Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity. 10:431.
Poluektova, L. Y., Munn, D. H., Persidsky, Y., and Gendelman, H. E., 2002, Generation of cytotoxic T-cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol. 168:3941.
Rizza, P., Santini, S. M., Logozzi, M. A., Lapenta, C., Sestili, P., Gherardi, G., Lande, R., Spada, M., Parlato, S., Belardelli, F., and Fais, S., 1996, T-cell dysfunction in hu-PBL-SCID mice infected with Human Immunodeficiency Virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells. J Virol. 70:7958.
Saeki, Y., Mima, T., Sakoda, S., Fujimura, H., Arita, N., Nomura, T., and Kishimoto, T., 1992, Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc Natl Acad Sci USA. 89:6157.
Safrit, J. T., Fung, M. S., Andrews, C. A., Braun, D. G., Sun, W. N., Chang, T. W., and Koup, R. A., 1993. Hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. AIDS. 7:15.
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., and Belardelli, F., 2000, Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med. 191:1777.
Scoggins, R. M., Taylor, J. R. Jr., Patrie, J., van’t Wout, A. B., Schuitemaker, H., and Camerini, D., 2000, Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J Virol. 74:3205.
Somasundaram, R., Jacob, L., and Herlyn, D., 1995, Tetanus toxoid-specific T-cell responses in severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood lymphocytes. Clin Exp Immunol. 101:94.
Sousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z., and Victorino, R. M., 2002, CD4 T-cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol. 169:3400.
Stevenson, M., Stanwick, T. L., Dempsey, M. P., and Lamonica, C. A., 1990, HIV-1 replication is controlled at the level of T-cell activation and proviral integration. EMBO J. 9:1551.
Tary-Lehmann, M., and Saxon, A., 1992, Human mature T-cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med. 175:503.
Tary-Lehmann, M., Saxon, A., and Lehmann, P. V., 1995, The human immune system in hu-PBL-SCID mice. Immunol Today. 16:529.
Van Kuyk, R., Torbett, B. E., Gulizia, R. J., Leath, S., Mosier, D. E., and Koenig, S., 1994, Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J Immunol. 153:4826.
Vieillard, V., Jouveshomme, S., Leflour, N., Jean-Pierre, E., Debre, P., De Maeyer, E., and Autran, B., 1999, Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection. J Virol. 73:10281.
Wang, C. Y., Sawyer, L. S., Murthy, K. K., Fang, X., Walfield, A. M., Ye, J., Wang, J. J., Chen, P. D., Li, M. L., Salas, M. T., Shen, M., Gauduin, M. C., Boyle, R. W., Koup, R. A., Montefiori, D. C., Mascola, J. R., Koff, W. C., and Hanson, C. V., 1999, Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex. Proc Natl Acad Sci USA. 96:10367.
Wang, E. J., Pettoello-Mantovani, M., Anderson, C. M., Osiecki, K., and Moskowitz, D., 2002, Goldstein, H., Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type1-infected cells. J Infect Dis. 186:1412.
Wang, E. J., Pettoello-Mantovani, M., Anderson, C. M., Osiecki, K., Moskowitz, D., and Goldstein, H., 2002, Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells J Infect Dis. 186:1412.
Zhang, C., Cui, Y., Houston, S., and Chang, L. J., 1996, Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals. Proc Natl Acad Sci USA. 93:14720.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Lapenta, C., Santini, S.M., Spada, M., Belardelli, F. (2006). SCID Mice Transplanted With Human Cells as Small Animal Models in AIDS Research. In: Friedman, H., Specter, S., Bendinelli, M. (eds) In vivo Models of HIV Disease and Control. Infectious Diseases and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-387-25741-1_4
Download citation
DOI: https://doi.org/10.1007/0-387-25741-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25740-2
Online ISBN: 978-0-387-25741-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)